110 research outputs found

    Sexual deviance in prison: Queering identity and intimacy in prison research

    Get PDF
    Recent years have seen increased attention in both research and policy towards Lesbian, Gay, Bisexual, and Transgender (LGBT) prisoners as a group with distinct needs. This has been driven by wider political recognition of LGBT rights and research suggesting that LGBT prisoners are particularly ‘vulnerable’ to bullying and abuse within prison settings. Much of this research, and the policy solutions associated with it, we argue, ignores or side-steps queer perspectives, relying instead on liberal conceptions of identity, vulnerability and, ultimately, assimilation. Just as contemporary campaigns around marriage rights see LGBT communities and individuals as fundamentally the same as the majority, rather than posing a challenge to the heteronormativity of marriage as an institution, much contemporary research and policy on LGBT prisoners sees this group as marked only by potential discrimination. We argue here instead that experiences of LGBT prisoners can be read ‘queerly’ so as to potentially challenge the rigid gender and heteronormative foundations that underlie systems of incarceration. We draw on a small-scale empirical research project around the experience of LGBT prisoners to revisit contemporary paradoxes of prisons and sexuality and to problematise understandings of identity, intimacy and deviance in the prison context

    Multidimensional severity assessment in bronchiectasis:An analysis of 7 European cohorts.

    Get PDF
    INTRODUCTION: Bronchiectasis is a multidimensional disease associated with substantial morbidity and mortality. Two disease-specific clinical prediction tools have been developed, the Bronchiectasis Severity Index (BSI) and the FACED score, both of which stratify patients into severity risk categories to predict the probability of mortality. METHODS: We aimed to compare the predictive utility of BSI and FACED in assessing clinically relevant disease outcomes across seven European cohorts independent of their original validation studies. RESULTS: The combined cohorts totalled 1612. Pooled analysis showed that both scores had a good discriminatory predictive value for mortality (pooled area under the curve (AUC) 0.76, 95% CI 0.74 to 0.78 for both scores) with the BSI demonstrating a higher sensitivity (65% vs 28%) but lower specificity (70% vs 93%) compared with the FACED score. Calibration analysis suggested that the BSI performed consistently well across all cohorts, while FACED consistently overestimated mortality in 'severe' patients (pooled OR 0.33 (0.23 to 0.48), p<0.0001). The BSI accurately predicted hospitalisations (pooled AUC 0.82, 95% CI 0.78 to 0.84), exacerbations, quality of life (QoL) and respiratory symptoms across all risk categories. FACED had poor discrimination for hospital admissions (pooled AUC 0.65, 95% CI 0.63 to 0.67) with low sensitivity at 16% and did not consistently predict future risk of exacerbations, QoL or respiratory symptoms. No association was observed with FACED and 6 min walk distance (6MWD) or lung function decline. CONCLUSION: The BSI accurately predicts mortality, hospital admissions, exacerbations, QoL, respiratory symptoms, 6MWD and lung function decline in bronchiectasis, providing a clinically relevant evaluation of disease severity

    Bronchiectasis insanity:Doing the same thing over and over again and expecting different results?

    Get PDF
    Bronchiectasis is an increasingly common disease with a significant impact on quality of life and morbidity of affected patients. It is also a very heterogeneous disease with numerous different underlying etiologies and presentations. Most treatments for bronchiectasis are based on low-quality evidence; consequently, no treatments have been approved by the US Food and Drug Administration or the European Medicines Agency for the treatment of bronchiectasis. The last several years have seen numerous clinical trials in which the investigational agent, thought to hold great promise, did not demonstrate a clinically or statistically significant benefit. This commentary will review the likely reasons for these disappointing results and a potential approach that may have a greater likelihood of defining evidence-based treatment for bronchiectasis

    Predominant pathogen competition and core microbiota divergence in chronic airway infection

    Get PDF
    © 2015 International Society for Microbial Ecology All rights reserved. Chronic bacterial lung infections associated with non-cystic fibrosis bronchiectasis represent a substantial and growing health-care burden. Where Pseudomonas aeruginosa is the numerically dominant species within these infections, prognosis is significantly worse. However, in many individuals, Haemophilus influenzae predominates, a scenario associated with less severe disease. The mechanisms that determine which pathogen is most abundant are not known. We hypothesised that the distribution of H. influenzae and P. aeruginosa would be consistent with strong interspecific competition effects. Further, we hypothesised that where P. aeruginosa is predominant, it is associated with a distinct 'accessory microbiota' that reflects a significant interaction between this pathogen and the wider bacterial community. To test these hypotheses, we analysed 16S rRNA gene pyrosequencing data generated previously from 60 adult bronchiectasis patients, whose airway microbiota was dominated by either P. aeruginosa or H. influenzae. The relative abundances of the two dominant species in their respective groups were not significantly different, and when present in the opposite pathogen group the two species were found to be in very low abundance, if at all. These findings are consistent with strong competition effects, moving towards competitive exclusion. Ordination analysis indicated that the distribution of the core microbiota associated with each pathogen, readjusted after removal of the dominant species, was significantly divergent (analysis of similarity (ANOSIM), R=0.07, P=0.019). Taken together, these findings suggest that both interspecific competition and also direct and/or indirect interactions between the predominant species and the wider bacterial community may contribute to the predominance of P. aeruginosa in a subset of bronchiectasis lung infections

    Understanding the impact of antibiotic therapies on the respiratory tract resistome: A novel pooled-template metagenomic sequencing strategy

    Get PDF
    Determining the effects of antimicrobial therapies on airway microbiology at a population-level is essential. Such analysis allows, for example, surveillance of antibiotic-induced changes in pathogen prevalence, the emergence and spread of antibiotic resistance, and the transmission of multi-resistant organisms. However, current analytical strategies for understanding these processes are limited. Culture- and PCR-based assays for specific microbes require the a priori selection of targets, while antibiotic sensitivity testing typically provides no insight into either the molecular basis of resistance, or the carriage of resistance determinants by the wider commensal microbiota. Shotgun metagenomic sequencing provides an alternative approach that allows the microbial composition of clinical samples to be described in detail, including the prevalence of resistance genes and virulence traits. While highly informative, the application of metagenomics to large patient cohorts can be prohibitively expensive. Using sputum samples from a randomised placebo-controlled trial of erythromycin in adults with bronchiectasis, we describe a novel, cost-effective strategy for screening patient cohorts for changes in resistance gene prevalence. By combining metagenomic screening of pooled DNA extracts with validatory quantitative PCR-based analysis of candidate markers in individual samples, we identify population-level changes in the relative abundance of specific macrolide resistance genes. This approach has the potential to provide an important adjunct to current analytical strategies, particularly within the context of antimicrobial clinical trials

    Digitized narratives of sexual violence: Making sexual violence felt and known through digital disclosures

    Get PDF
    In this article, we argue that social media platforms like Tumblr and Twitter have facilitated an emergence of “digitized narratives” of sexual violence. These narratives are rooted in historical ways in which feminists have discursively articulated sexual violence, yet are shaped by distinctive “platform vernacular” or the conventions, affordances, and restrictions of the platforms in which they appear. Drawing on a qualitative content and critical discourse analysis of 450 texts from the Tumblr site Who Needs Feminism? and the hashtag #BeenRapedNeverReported, we argue that digital platforms such as Tumblr and Twitter produce new vernacular practices which shape how “digitized narratives” of sexual violence are not only disclosed and known, but felt and experienced across digital networks
    corecore